Immunological
1888 — Description by Jan Mikulicz-Radecki, published in German medical literature
Sjögren's syndrome was a condition that took centuries of fragmented clinical observation before emerging as a recognized immunological entity in the early twentieth century. Physicians had long noted patients suffering from dryness of the eyes and mouth but lacked a unifying framework to explain the constellation of findings. It was the meticulous work of a Swedish ophthalmologist in the 1930s that finally drew these threads together into a coherent clinical picture.
Historical Narrative
The earliest hints of what would later be called Sjögren's syndrome appeared in scattered European medical literature of the nineteenth century, where physicians recorded unusual cases of patients presenting with chronically dry eyes and mouths alongside swollen glands, conditions that confounded practitioners who had no systematic way of linking such seemingly disparate complaints. Polish physician Jan Mikulicz-Radecki described in 1888 a patient with bilateral swelling of the lacrimal and salivary glands, a case that became one of the first formally documented in the medical record and which the medical community would later debate in relation to the syndrome's history. Mikulicz's observations were largely filed under a vague designation of glandular swelling, and no immunological mechanism was conceived of at the time, as the science of immunology itself remained in its infancy.
Throughout the late nineteenth and early twentieth centuries, European clinicians continued to publish isolated case reports of patients with glandular involvement and mucosal dryness, but these accounts existed in isolation from one another, products of different specialties and different national medical traditions that rarely communicated across disciplinary lines. Ophthalmologists saw the dry eye manifestations as a problem of tear production, while internists focused on the glandular swellings, and neither group had developed the conceptual vocabulary to unite these presentations.
The pivotal moment in the syndrome's history came with the 1933 doctoral thesis of Henrik Sjögren, a Swedish ophthalmologist working in Stockholm. Sjögren examined nineteen patients who shared dryness of the eyes, a condition he termed keratoconjunctivitis sicca, along with dry mouth and in many cases arthritis. His methodical clinical and histological investigations led him to argue that this was a systemic disease rather than a local ocular disorder, a claim that was initially met with considerable skepticism from the broader medical community. Sjögren faced resistance from colleagues who doubted the systemic nature of the condition and questioned whether the cases truly represented a unified disease entity.
Despite early resistance, Sjögren's work gradually attracted international attention through the 1940s and 1950s, particularly as rheumatologists began recognizing the syndrome's frequent association with other conditions such as rheumatoid arthritis. British and American physicians began incorporating Sjögren's descriptions into their own clinical thinking, and the syndrome began appearing in textbooks under his name. The mid-twentieth century saw growing attempts to understand the pathological changes in affected glandular tissue, with histological studies revealing lymphocytic infiltration that pointed toward an immunological rather than infectious or degenerative cause.
The advent of modern immunological research tools in the 1960s and 1970s transformed understanding of the condition. Investigators identified specific autoantibodies in patients, designated anti-Ro and anti-La, which became important markers in the laboratory characterization of the disease and helped separate it from overlapping conditions. These discoveries positioned the syndrome firmly within the landscape of autoimmune disease, a category that had itself only recently solidified as a legitimate medical concept. By the latter decades of the twentieth century, Sjögren's syndrome had become one of the more studied autoimmune conditions, with researchers across Europe, Japan, and North America contributing to classification criteria that standardized how the medical community historically defined and grouped affected patients for research purposes.
Key Historical Figures
Historical narrative only — this page describes how Sjögren's syndrome was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.